Literature DB >> 12975031

Nutrition therapy for hypertension.

Elise Zimmerman1, Judith Wylie-Rosett.   

Abstract

A contemporary approach to hypertension and prevention are covered in this article. It contains important information for clinicians, such as hypertension management, metabolic syndrome issues, lifestyle behavioral management, nutrient issues, weight loss treatments (ie, medications and surgical procedures), the role of physical activity, and pharmacologic treatment. The Dietary Approaches to Stop Hypertension (DASH) trial eating plan is discussed at length, as well as information from recent trials on hypertension, prevention, and treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975031     DOI: 10.1007/s11892-003-0085-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  41 in total

1.  Coffee intake and risk of hypertension: the Johns Hopkins precursors study.

Authors:  Michael J Klag; Nae-Yuh Wang; Lucy A Meoni; Frederick L Brancati; Lisa A Cooper; Kung-Yee Liang; J Hunter Young; Daniel E Ford
Journal:  Arch Intern Med       Date:  2002-03-25

2.  Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking.

Authors:  Roberto Corti; Christian Binggeli; Isabella Sudano; Lukas Spieker; Edgar Hänseler; Frank Ruschitzka; William F Chaplin; Thomas F Lüscher; Georg Noll
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

3.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

4.  Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial.

Authors:  J H John; S Ziebland; P Yudkin; L S Roe; H A W Neil
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

5.  Physical activity/exercise and diabetes mellitus.

Authors:  Bernard Zinman; Neil Ruderman; Barbara N Campaigne; John T Devlin; Stephen H Schneider
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

6.  Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study.

Authors:  Mark A Pereira; David R Jacobs; Linda Van Horn; Martha L Slattery; Alex I Kartashov; David S Ludwig
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

9.  Persistence of normotension after discontinuation of lifestyle intervention in the trial of TONE. Trial of Nonpharmacologic Interventions in the Elderly.

Authors:  John B Kostis; Alan C Wilson; Daniel M Shindler; Nora M Cosgrove; Clifton R Lacy
Journal:  Am J Hypertens       Date:  2002-08       Impact factor: 2.689

10.  Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

Authors:  Richard J Woodman; Trevor A Mori; Valerie Burke; Ian B Puddey; Gerald F Watts; Lawrence J Beilin
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.